Abstract
Background. Oral hormonal contraception (HC) is the most widespread and effective system of pregnancy prevention in all industrialized countries. The effectiveness of the method in real practice depends on the drug being taken correctly, which therefore means complying with the right dosage. Aims. This study aimed to assess the cost of preventing pregnancy and its complications with conventional hormonal contraception and with HC in the form of a recently introduced transdermal patch. A five-year projection model was set up for possible events (extrauterine pregnancy, voluntary and spontaneous abortion, and childbirth), and the economic impact of the two different contraceptive strategies on those events was assessed. Results. From a pharmacoeconomic point of view, the patch is a better choice than oral contraceptives, and the economic benefits in the youngest age groups (age
| Translated title of the contribution | Cost analysis of the use of a new transdermally administered hormonal contraceptive |
|---|---|
| Original language | Italian |
| Pages (from-to) | 277-283 |
| Number of pages | 7 |
| Journal | Trends in Medicine |
| Volume | 6 |
| Issue number | 4 |
| Publication status | Published - Oct 2006 |
ASJC Scopus subject areas
- Internal Medicine
- Pharmacology (medical)